Qiagen NV | QIA - Selling And Administration Expenses

Stock Price
40.40
Daily Change
-0.59 -1.43%
Monthly
-12.99%
Yearly
5.50%
Q1 Forecast
40.37

Qiagen NV reported $153.88M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 25.74M 1.93M Mar/2025
Alaunos Therapeutics USD 585K 260K Sep/2025
argenx SE USD 336.29M 14.94M Sep/2025
Avita Medical AUD 20.98M 253K Jun/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
IQVIA Holdings USD 468M 46M Dec/2025
Moderna USD 308M 40M Dec/2025
Organon & Co USD 399M 54M Sep/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Tectonic Therapeutic USD 4.96M 190K Sep/2025
Viatris USD 886.6M 42.1M Sep/2025
Xeris Pharmaceuticals USD 46.46M 2.07M Sep/2025